ANDA 85938, held by Sandoz. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85938 (Butabarbital Sodium), held by Sandoz, was first approved by FDA on Sep 16, 1994, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium15MG ยท tablet;oral | Butabarbital Sodium | DiscontinuedReference drug |
| Sep 16, 1994 | Original application | Approved | None posted |
| Oct 7, 1985 | Supplement 11Manufacturing | Approved | None posted |
| Aug 11, 1983 | Supplement 8Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters